Next Article in Journal
Antiproliferative Activity of Fucan Nanogel
Previous Article in Journal
Antinociceptive and Anti-Inflammatory Activities of Crude Methanolic Extract of Red Alga Bryothamnion triquetrum

Mar. Drugs 2012, 10(9), 1993-2001; doi:10.3390/md10091993

Meroterpenes from Endophytic Fungus A1 of Mangrove Plant Scyphiphora hydrophyllacea
Wen-Li Mei 1,, Bo Zheng 1,2,, You-Xing Zhao 1, Hui-Ming Zhong 2, Xun-Li Wu Chen 1, Yan-Bo Zeng 1, Wen-Hua Dong 1, Jiu-Li Huang 1, Peter Proksch 3 and Hao-Fu Dai 1,*
Key Laboratory of Biology and Genetic Resources of Tropical Crops, Ministry of Agriculture, Institute of Tropical Bioscience and Biotechnology, Chinese Academy of Tropical Agriculture Sciences, Haikou 571101, China; Email:
College of Chemistry and Molecular Engineering, Qingdao University of Science and Technology, Qingdao 266042, China; Email:
Institute of Pharmaceutical Biology and Biotechnology, Heinrich-Heine-Universitaet Duesseldorf, Duesseldorf 40225, Germany; Email:
These authors contributed equally to this work.
Author to whom correspondence should be addressed; Email: Tel./Fax: +86-898-6696-1869.
Received: 3 July 2012; in revised form: 10 August 2012 / Accepted: 4 September 2012 / Published: 17 September 2012


: Four new meroterpenes, guignardones F–I (14), together with two known compounds guignardones A (5) and B (6) were isolated from the endophytic fungus A1 of the mangrove plant Scyphiphora hydrophyllacea. Their structures and relative configurations were elucidated by spectroscopic data and single-crystal X-ray crystallography. A possible biogenetic pathway of compounds 16 was also proposed. All compounds were evaluated for inhibitory activity against methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus.
marine endophyte; Scyphiphora hydrophyllacea; meroterpenes; Guignardia sp.; MRSA; Staphylococcus aureus

1. Introduction

Marine-derived fungi have recently become a research focus as one of the richest sources of new and bioactive secondary metabolites in the marine environment [1,2]. The mangrove plant Scyphiphora hydrophyllacea Gaertn. F. (Rubiaceae) growing in tropical and subtropical intertidal habitats is a rich source of new iridoids, which have been found to possess cytotoxic activity [3,4,5,6]. The metabolites produced by endophytic fungi from S. hydrophyllacea collected in Hainan attracted our attention [7], a new fatty acid glycoside and two new meroterpenes have been found from the fungus A1 of S. hydrophyllacea [8,9]. Further phytochemical investigation of the secondary metabolites from the culture broth of the fungus A1 led to the isolation of four new meroterpenes, guignardones F–I (14) (Figure 1), and two known compounds, guignardones A (5) and B (6) [10]. This paper reports the isolation and structural elucidation, as well as biological activities and plausible biogenetic pathway of these compounds.

Figure 1. The structures of compounds 16.
Figure 1. The structures of compounds 16.
Marinedrugs 10 01993 g001 1024

2. Results and Discussion

Guignardone F (1) was isolated as colorless needle crystals, and possessed a molecular formula of C17H24O5 as established by HREIMS (m/z 308.1625 [M]+), indicating six degrees of unsaturation. The IR spectrum displayed hydroxyl (3463 cm−1), conjugated carbonyl (1657 cm−1) and double bond (1606 cm−1) absorptions. In the 13C NMR and DEPT spectra (Table 1), a total of 17 carbon resonances were found and classified into three methyls, five methylenes (one oxygenated), three methines (one oxygenated), and six quaternary carbons (one α,β-unsaturated carbonyl unit, three oxygenated). In the HMBC spectrum (Figure 2), the correlations from H2-8 (δH 3.03, 1.92) to C-1 (δC 200.2), C-2 (δC 114.7), and C-3 (δC 173.9), from H-4 (δH 4.46) to C-2 and C-6 (δC 81.8), from H2-5 (δH 2.31, 1.91) to C-1 and C-3, and from H2-7 (δH 3.80, 3.45) to C-4 (δC 81.3), C-5 (δC 42.5), and C-6 were found and led to the establishment of partial structure 1a, which was identical to that of guignardone B (6) [10]. In the 1H-1H COSY spectrum, a proton spin system (H-8/H-9/H-14/H-13/H-12) was found as drawn with bond lines in Figure 2. In addition, the HMBC cross-peaks from H3-11 (δH 1.35) to C-9 (δC 46.1), C-10 (δC 80.5), and C-12 (δC 39.3), and from both H3-16 (δH 1.17) and H3-17 (δH 1.45) to C-14 (δC 54.1) and C-15 (δC 86.9) determined the establishment of substructure 1b. Careful comparison of the 13C NMR data of 1 with those of 6, the upfield shift of C-10 (Δ −10.2 ppm) and the downfield shift of C-15 (Δ +14.0 ppm) were observed. So it was proposed that C-3 connected with C-15 via an ether bond to form a seven-membered ring in 1, instead of the C-3 connected with C-10 via an ether bond to form a six-membered ring in 6. This also gave a good explanation for the obvious difference (Δ 10.8 ppm) of chemical shifts between the 16-CH3 and the 17-CH3, since their stereochemistry circumstance was quite different in the structure of 1. Thus, the gross structure of 1 was elucidated and further confirmed by X-ray crystallography which also established its relative configuration (Chart 1). Therefore, the structure of 1 was established as shown in Figure 1, named Guignardone F (1).

Table 1. 13C NMR data (100 MHz, CDCl3) for 14.
Table 1. 13C NMR data (100 MHz, CDCl3) for 14.
1200.2 s198.7 s194.9 s195.0 s
2114.7 s105.0 s105.8 s105.5 s
3173.9 s167.1 s167.7 s168.5 s
481.3 d66.7 d65.7 d65.7 d
542.5 t36.9 t34.5 t34.6 t
681.8 s67.1 d79.1 d79.0 d
769.3 t
821.9 t16.2 t16.1 t18.7 t
946.1 d43.3 d43.2 d41.2 d
1080.5 s88.2 s87.7 s88.9 s
1126.5 q23.5 q22.3 q22.1 q
1239.3 t37.7 t37.4 t38.3 t
1325.9 t27.0 t26.9 t24.5 t
1454.1 d48.7 d48.9 d51.1 d
1586.9 s145.4 s145.4 s72.9 s
1619.2 q111.3 t111.2 t28.6 q
1730.0 q19.2 q19.2 q27.5 q
OCH3 58.3 q58.3 q
Figure 2. 1H-1H COSY and key HMBC correlations of 14.
Figure 2. 1H-1H COSY and key HMBC correlations of 14.
Marinedrugs 10 01993 g002 1024
Chart 1. The ORTEP view of compound 1.
Chart 1. The ORTEP view of compound 1.
Marinedrugs 10 01993 g004 1024

Guignardone G (2) was obtained as a colorless oil. Its molecular formula was determined as C16H22O4 from [M]+ ion peak at m/z 278.1513 in the HREIMS, with six degrees of unsaturation. IR absorptions implied the presence of hydroxyl (3440 cm−1), conjugated carbonyl (1653 cm−1) and double bond (1622 cm−1) groups. The 13C NMR and DEPT spectra (Table 1) revealed 16 carbon signals, including one α,β-unsaturated carbonyl group, one terminal double bond, one oxygenated quaternary carbon, four methines (two oxygenated), four methylenes, and two methyls. Apart from one carbonyl and two double bonds, the remaining degrees of unsaturation indicated that 2 possessed a tricyclic system. Detailed analysis of its 1H NMR and 13C NMR spectra showed that compound 2 was analogous to guignardone A (5) [10], except for the absence of a methylene (C-7), a quaternary carbon (C-6) in 5 and the presence of a methine (C-6) in 2. In addition, the 13C NMR signals of C-4 upshifted from δC 78.5 to δC 66.7 and C-5 from δC 44.0 to δC 36.9. Base on the above evidence, it was supposed that the C-7 of 5 was degraded and the corresponding ring was broken to form the structure of 2, which was confirmed by 2D NMR experiments. The relative configuration of 2 was assigned by a ROESY experiment and comparison with 5. H-9 (δH 1.95) showed correlations to both H3-11 (δH 1.32) and H2-16 (δH 4.64), which indicated that when H-9 and CH3-11 possess α-orientation, H-14 (δH 2.27) will possess β-orientation, as in accordance with the relative configuration of 5 (Figure 3). The α-orientation of H-4 (δH 4.35) was also tentatively established as same as that of 5 for the biogenetic pathway consideration. H-6 (δH 4.48, dd, J = 11.9, 5.4 Hz) exhibited ROESY correlation with H-4, and the large vicinal coupling constant (J = 11.9 Hz) established the pseudoaxial position for H-6. So H-6 was established as α-oriented. Thus, the structure of 2 was established and named guignardone G.

Figure 3. Selected ROESY correlations of 24.
Figure 3. Selected ROESY correlations of 24.
Marinedrugs 10 01993 g003 1024

Guignardone H (3) was isolated as a colorless oil. The HRTOFMS of 3 showed a pseudo-molecular ion peak at m/z 293.1745 [M + H]+ corresponding to the molecular formula C17H24O4, implying six degrees of unsaturation. The 1H NMR and 13C NMR spectra of 3 (Table 1 and Table 2) were strikingly similar to those of 2, with the only obvious difference being the presence of a methoxy (δH 3.47, 3H, s; δC 58.3) group in 3. The HMBC correlations of the methoxy protons to C-6 (δC 79.1) and from H-6 (δH 3.70) to the methoxy carbon indicated that the methoxy group located at C-6. β-orientations of OH-4 and H-14 and α-orientations of H-9 and CH3-11 were established by ROESY correlations and comparison with 2 and proved to be the same as 2. There was no ROESY correlation between H-6 (δH 3.70, dd, J = 6.8, 3.6 Hz) and H-4 (δH 4.24), and the proton coupling constants between H-6 and H2-5 (δH 2.35, 2.23) were 6.8 and 3.6 Hz, differed from those of H-6 in 2. Hence, H-6 was deduced to be β-oriented. Thus, the structure of 3 was established as shown (Figure 1) and named guignardone H.

Table 2. 1H NMR data (400 MHz, CDCl3) for 14.
Table 2. 1H NMR data (400 MHz, CDCl3) for 14.
44.46, d (5.2)4.35, br t (2.8)4.24, br s4.26, br s
52.31, m2.53, dq (13.4, 5.4)2.35, m2.38, dt (13.6, 4.2)
1.91, m2.01, m2.23, m2.23, m
6 4.48, dd (11.9, 5.4)3.70, dd (6.8, 3.6)3.71, dd (7.0, 3.6)
73.80, d (8.0)
3.45, d (8.0)
83.03, dd (15.0, 3.2)2.32, m2.33, d (17.3)2.62, d (17.6)
1.92, m2.28, m 2.15, m2.26, m
91.40, dd (12.0, 3.2)1.95, m1.94, m2.04, m
111.35, s, 3H1.32, s, 3H1.33, s, 3H1.33, s, 3H
121.76, m, 2H2.10, m; 1.81, m2.13, m; 1.79, m2.01, m; 1.59, m
131.95, m; 1.22, m1.94, m; 1.57, m1.91, m; 1.53, m1.79, m; 1.58, m
142.33, m2.27, m2.17, m1.58, m
161.17, s, 3H4.73, m4.72, m1.20, s, 3H
4.64, m4.62, m
171.45, s, 3H1.66, s, 3H1.65, s, 3H1.18, s, 3H
OCH3 3.47, s, 3H3.47, s, 3H

Guignardone I (4) was obtained as a colorless oil. The molecular formula was deduced as C17H26O5 on the basis of its HREIMS ion peak at m/z 310.1783 [M]+ with five degrees of unsaturation. The 1H NMR and 13C NMR data (Table 1 and Table 2) of 4 closely resembled those of 3, except for the disappearance of an exocyclic double bond and the presence of an oxygenated quarternary carbon (C-15, δC 72.9) and a methyl group (C-16, δC 28.6) in 4. Therefore, it was supposed that compound 4 may derived from 3 by hydroxylation at the exocyclic double bond, which was confirmed by the HMBC correlations of H3-16 (δH 1.20) with C-14 (δC 51.1), C-15 (δC 72.9), and C-17 (δC 27.5). The ROESY correlations and chemical shifts at chiral centers of 4 were similar to those of 3, which showed the same relative configurations at C-4, C-6, C-9, C-10, and C-14.

A possible biogenetic pathway of compounds 16 was proposed as shown in Scheme 1. Guignardone A (5), a major product isolated in this experiment, was taken as the biogenetic precursor. Two ether bonds were suitable for the enzymatic opening that resulted in a 3,10-dihydroxy intermediate (i) and a 4,7-dihydroxy intermediate (ii). The five-membered ring and the connected isopropanol group of intermediate i could turn upside-down around the bond C-8–C-9 to generate 1. The intermediate ii underwent an oxidation and decarboxylation to give an intermediate (iii). Afterward, the intermediate (iii) converted to its C-1 ketone isomer. This assumption reasonably accounted for the simultaneous occurrences of β-orientation of OH-6 in 2 and α-orientation of OCH3 in 3.

Scheme 1. Plausible biosynthetic pathway of 16.
Scheme 1. Plausible biosynthetic pathway of 16.
Marinedrugs 10 01993 g005 1024

All compounds were tested for antibacterial activities against methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus. Guignardone I (4) exhibited inhibition zones of 9.0 and 11.0 mm in diameter (the diameter of sterile filter paper discs was 6 mm) toward MRSA and S. aureus at 65 µM, respectively. Guignardone B (6) gave an inhibition zone of 8.0 mm against MRSA at 65 µM. The other compounds have not show any antibacterial action under the same conditions. 10 µL 0.08 mg mL−1 kanamycin sulfate was used as positive control, for which the diameter of the inhibition zone was 30 mm.

3. Experimental Section

3.1. General Experimental Procedures

Optical rotations were taken on a Rudolph Autopol Ш. IR spectra were measured on a Nicolet 380 FT-IR instrument with KBr pellets. NMR spectra were recorded on a Bruker AM-400 spectrometer at 400 MHz for 1H NMR and at 100 MHz for 13C NMR using TMS as an internal standard. MS spectra were obtained on a VG Auto Spec-3000 mass spectrometer (VG, Manchester, UK). Column chromatography was performed on silica gel (200–300 mesh; Qingdao Marine Chemical Inc., Qingdao, People’s Republic of China). Sephadex LH-20 for chromatography was purchased from Merck (Germany). TLC was performed with silica gel GF254 (Marine Chemical Inc, Qingdao, China), and spots were visualized by heating silica gel plates sprayed with 10% H2SO4 in EtOH.

3.2. Fungal Material and Fermentation

The marine-derived fungus A1 was isolated from the leaves of mangrove plant Scyphiphora hydrophyllacea Gaertn. F. (Rubiaceae) (No. SH20081205), which were collected in Wenchang County in Hainan Province (China) in December 2008. The strain, which was identified as a Guignardia sp. based on the ITS sequences, was deposited in the Institute of Tropical Bioscience and Biotechnology, Chinese Academy of Tropical Agricultural Sciences, Haikou, China, and maintained on potato dextrose agar (PDA) slant at 4 °C. The marine-derived fungus A1 was grown on PDA at room temperature for 5 days. Three pieces of mycelial agar plugs (0.5 × 0.5 cm2) were inoculated into 1 L Erlenmeyer flasks containing 300 mL potato dextrose broth. The cultivation was shaken at 120 rpm at room temperature for 7 days, and then kept in still at room temperature for 45 days.

3.3. Extraction and Isolation

The culture broth (130 L) was filtered to give the filtrate and mycelia. The filtrate was evaporated in vacuo to small volume and then partitioned in succession between H2O and petroleum ether, EtOAc, n-Butanol. The EtOAc solution was evaporated under reduced pressure to give a crude extract (10.5 g), which was separated into 11 fractions (Fr.1–Fr.11) on a silica-gel column using a step gradient elution of CHCl3/MeOH (1:0→0:1). The Fr.1 (732 mg) was firstly subjected to Sephadex LH-20 (CHCl3/MeOH, 1:1) CC, then subjected to silica gel CC (Pet/EtOAc 12:1, Pet/acetone 10:1) repeatedly to give 5 (80.6 mg) and 3 (12.5 mg). The Fr.3 (583 mg) was subjected to silica gel CC (Pet/Acetone 8:1 to 1:1, Pet/EtOAc 6:1, CHCl3/EtOAc 6:1) repeatedly, and further purified by Sephadex LH-20 (CHCl3/MeOH, 1:1) CC to give 1 (11.3 mg), 2 (8.5 mg), and 6 (6.2 mg). The Fr.4 (468 mg) was purified by silica gel CC (Pet/Acetone 6:1 to 1:1, Pet/EtOAc 4:1, CHCl3/MeOH 40:1) repeatedly to give 4 (9.2 mg).

Guignardone F (1): Colorless needle crystals; [α]32D−42 (c 0.20, MeOH); IR (KBr) νmax 3463, 3285, 2973, 2942, 2877, 1657, 1606, 1455, 1375, 1232, 1186, 1131, 1092, 1021 cm−1; 1H and 13C NMR, see Table 1 and Table 2; HREIMS m/z 308.1625 [M]+ (calcd for C17H24O5, 308.1624).

Guignardone G (2): Colorless oil; [α]32D +3.5 (c 0.32, MeOH); IR (KBr) νmax 3440, 2955, 2925, 2854, 1653, 1622, 1458, 1378, 1167, 1099, 1059 cm−1; 1H and 13C NMR, see Table 1 and Table 2; HREIMS m/z 278.1513 [M]+ (calcd for C16H22O4, 278.1518).

Guignardone H (3): Colorless oil; [α]32D +8.9 (c 0.34, MeOH); IR (KBr) νmax 3439, 2927, 1658, 1616, 1442, 1394, 1378, 1168, 1077, 1019, 890 cm−1; 1H and 13C NMR, see Table 1 and Table 2; HRTOFMS m/z 293.1745 [M + H]+ (calcd for C17H25O4, 293.1752).

Guignardone I (4): Colorless oil; [α]32D −32 (c 0.24, MeOH); IR (KBr) νmax 3440, 2968, 2930, 1654, 1613, 1458, 1396, 1379, 1364, 1281, 1164, 1131, 1077, 1020, 887 cm−1; 1H and 13C NMR, see Table 1 and Table 2; HREIMS m/z 310.1783 [M]+ (calcd for C17H26O5, 310.1780).

Crystallographic data for Guignardone F (1): C17H24O5; MW = 308.36; Monoclinic, space group C2; 9.7072 (17) Å, b =9.7382 (16) Å, c = 16.752 (3) Å, α =β =γ = 90°, V = 1583.6 (5) Å3, Z = 4, d = 1.293 g/cm3, crystal dimensions 0.08 × 0.20 × 0.70 mm3.

3.4. Antibacterial Activity

Compounds 16 were tested for antibacterial activity against S. aureus and MRSA strains (obtained from the Food and Drug Administration of Hainan Province, Haikou, China) using the filter paper disc agar diffusion method [11]. The strains were cultured using nutrient agar. Fifty microliters (28 mM) of the compound were impregnated on sterile filter paper discs (6-mm diameter), and then, aseptically applied to the surface of the agar plates. Ten microliters (0.08 mg/mL) of kanamycin sulfate were used as positive control. Then the diameters of inhibition zones were measured after 24 h incubation at room temperature. Experiments were done in triplicate, and the results presented as mean values of the three measurements.

4. Conclusions

Four new meroterpenes, guignardones F–I (1–4), together with two known compounds guignardones A (5) and B (6), were isolated from the endophytic fungus A1 Guignardia sp. of mangrove plant Scyphiphora hydrophyllacea. The plane structure of guignardone G was same as coibanol A, one of the three tricyclic meroterpenes isolated from an endophytic fungus Pycnoporus sanguineus. The H-9 and CH3-11 possess α-orientations in compounds 1–6, different from the β-orientation in coibanols A–C [12]. The plane structure of guignardone H was same as tricycloalternarene F, another tricyclic meroterpene isolated from an endophytic fungus Guignarda mangiferae, the stereochemistry of which has not been clarified [13]. Guignardones A (5) and B (6) with an additional tetrahydrofuran ring in their structure have been isolated from a fungus Guignardia mangiferae associated with normal Ilex cornuta leaves [10]. Especially, compound 1 possessed a novel structure, beside an additional tetrahydrofuran ring, the six-membered ring possessing an oxygen atom was changed to a seven-membered ring. Antibacterial tests demonstrated that guignardone I (4) showed modest inhibitory effects on Staphylococcus aureus and MRSA, diameters of inhibition zones of which were 9.0 and 11.0 mm, respectively. Guignardone B (6) exhibited weak antibacterial activity against MRSA with a diameter of inhibition zones of 8.0 mm.


This work was supported by National Natural Science Foundation of China (No.30560018, No.20862020), and National Non-profit Institute Research Grant of ITBB (ITBBZD0841). The authors also thank the members of the analytical group of the State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, for the spectral measurements.


  1. Blunt, J.W.; Copp, B.R.; Hu, W.P.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natrual products. Nat. Prod. Rep. 2009, 26, 170–244. [Google Scholar] [CrossRef]
  2. Blunt, J.W.; Copp, B.R.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natrual products. Nat. Prod. Rep. 2010, 27, 165–237. [Google Scholar] [CrossRef]
  3. Zeng, Y.B.; Mei, W.L.; Zhao, Y.X.; Zhuang, L.; Hong, K.; Dai, H.F. Two new epimeric pairs of iridoid from mangrove plant Scyphiphora hydrophyllacea. Chin. Chem. Lett. 2007, 18, 1509–1511. [Google Scholar] [CrossRef]
  4. Zeng, Y.B.; Mei, W.L.; Zhao, Y.X.; Dai, H.F. Two new noriridoids from Scyphiphora hydrophyllacea. Z. Naturforschung B 2008, 63, 108–110. [Google Scholar]
  5. Zeng, Y.B.; Mei, W.L.; Wang, H.; Li, X.N.; Dai, H.F. Scyphiphin D, a new iridoid glucoside dimer from Scyphiphora hydrophyllacea. J. Asian Nat. Prod. Res. 2010, 12, 1010–1014. [Google Scholar] [CrossRef]
  6. Feng, C.L.; Gong, M.F.; Zeng, Y.B.; Dai, H.F.; Mei, W.L. Scyphiphin C, a new iridoid from Scyphiphora hydrophyllacea. Molecules 2010, 15, 2473–2477. [Google Scholar] [CrossRef]
  7. Zeng, Y.B.; Dai, H.F.; Huang, J.L.; Mei, W.L. Separation, purification and structural elucidation of the bio-active components from fermentation broth of endophytic fungus C22 from Scyphiphora hydrophyllacea. Chin. J. Antibiot. 2011, 36, 276–279. [Google Scholar]
  8. Zeng, Y.B.; Wang, H.; Zuo, W.J.; Zheng, B.; Yang, T.; Dai, H.F.; Mei, W.L. A fatty acid glycoside from a marine-derived fungus isolated from mangrove plant Scyphiphora hydrophyllacea. Mar. Drugs 2012, 10, 598–603. [Google Scholar] [CrossRef]
  9. Zheng, B.; Zeng, Y.B.; Dai, H.F.; Zuo, W.J.; Guo, Z.K.; Yang, T.; Zhong, H.M.; Mei, W.L. Two new meroterpenes from endophytic fungus A1 of Scyphiphora hydrophyllacea. J. Asian Nat. Prod. Res. 2012, 14, 776–779. [Google Scholar] [CrossRef]
  10. Yuan, W.H.; Liu, M.; Jiang, N.; Guo, Z.K.; Ma, J.; Zhang, J.; Song, Y.C.; Tan, R.X. Guignardones A–C: Three meroterpenes from Guignardia mangiferae. Eur. J. Org. Chem. 2010, 33, 6348–6353. [Google Scholar]
  11. Xu, S.Y.; Bian, R.L.; Chen, X. Methods of Pharmacology Experiment; People’s Sanitation Press: Beijing, China, 2003; pp. 1651–1653. [Google Scholar]
  12. Molinar, E.; Rios, N.; Spadafora, C.; Arnold, A.E.; Coley, P.D.; Kursar, T.A.; Gerwick, W.H.; Cubilla-Rios, L. Coibanoles, a new class of meroterpenoids produced by Pycnoporus sanguineus. Tetrahedron Lett. 2012, 53, 919–922. [Google Scholar] [CrossRef]
  13. Denise, O.G.; Norberto, P.L.; Monica, T.P. Meroterpenes isolated from the endophytic fungus Guignardia mangiferae. Phytochem. Lett. 2012, 5, 519–523. [Google Scholar] [CrossRef]
  • Samples Availability: Available from the authors.
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert